TDMS Study 91001-01 Pathology Tables

NTP Experiment-Test: 91001-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: SUBCHRON 90-DAY                                  O-CHLOROANILINE                                      Date: 10/20/04
Route: GAVAGE                                                                                                     Time: 13:20:52
       Facility:  Battelle Columbus Laboratory
       Chemical CAS #:  95-51-2
       Lock Date:  09/03/92
       Cage Range:  All
       Reasons For Removal:    All
       Removal Date Range:     All
       Treatment Groups:       Include 002    0 MG/KG
                               Include 001    0 MG/KG
                               Include 004    10 MG/KG
                               Include 003    10 MG/KG
                               Include 006    20 MG/KG
                               Include 005    20 MG/KG
                               Include 008    40 MG/KG
                               Include 007    40 MG/KG
                               Include 010    80 MG/KG
                               Include 009    80 MG/KG
                               Include 012    160     MG/KG
                               Include 011    160     MG/KG
a  Number of animals examined microscopically at site and number of animals with lesion
                                                              Page   1
NTP Experiment-Test: 91001-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: SUBCHRON 90-DAY                                  O-CHLOROANILINE                                      Date: 10/20/04    
Route: GAVAGE                                                                                                     Time: 13:20:52    
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS FEMALE                   0 MG/KG      10 MG/KG     20 MG/KG     40 MG/KG     80 MG/KG     160             
                                                                                                                    MG/KG           
____________________________________________________________________________________________________________________________________
DISPOSITION SUMMARY                                                                                                                 
  Animals Initially In Study                          10           10           10           10           10           10           
  Early Deaths                                                                                                                      
    Natural Death                                                                1                                                  
  Survivors                                                                                                                         
    Terminal Sacrifice                                10           10            9           10           10           10           
  Animals Examined Microscopically                    10           10           10           10           10           10           
____________________________________________________________________________________________________________________________________
 ALIMENTARY SYSTEM                                                                                                                  
   Liver                                              (10)                      (1)                                    (10)         
      Pigmentation, Hemosiderin                                                                                        10 (100%)    
____________________________________________________________________________________________________________________________________
 CARDIOVASCULAR SYSTEM                                                                                                              
   Heart                                              (10)                      (1)                                    (10)         
      Myocardium, Degeneration, Chronic, Focal                                                                          1 (10%)     
____________________________________________________________________________________________________________________________________
 ENDOCRINE SYSTEM                                                                                                                   
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
 GENERAL BODY SYSTEM                                                                                                                
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
 GENITAL SYSTEM                                                                                                                     
   Clitoral Gland                                     (10)                      (1)                                    (10)         
      Inflammation, Chronic Active                     3 (30%)                                                          1 (10%)     
   Ovary                                              (10)                      (1)                                    (10)         
      Periovarian Tissue, Cyst                         1 (10%)                                                                      
____________________________________________________________________________________________________________________________________
 HEMATOPOIETIC SYSTEM                                                                                                               
   Bone Marrow                                        (10)         (10)         (10)         (10)         (10)         (10)         
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    2                                                              
NTP Experiment-Test: 91001-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: SUBCHRON 90-DAY                                  O-CHLOROANILINE                                      Date: 10/20/04    
Route: GAVAGE                                                                                                     Time: 13:20:52    
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS FEMALE                   0 MG/KG      10 MG/KG     20 MG/KG     40 MG/KG     80 MG/KG     160             
                                                                                                                    MG/KG           
____________________________________________________________________________________________________________________________________
HEMATOPOIETIC SYSTEM - CONT                                                                                                         
      Erythroid Cell, Hyperplasia                                                                         10 (100%)    10 (100%)    
   Spleen                                             (10)         (10)         (10)         (10)         (10)         (10)         
      Hematopoietic Cell Proliferation                                                                    10 (100%)    10 (100%)    
      Pigmentation, Hemosiderin                                                                            9 (90%)      9 (90%)     
      Capsule, Fibrosis                                                                                   10 (100%)    10 (100%)    
____________________________________________________________________________________________________________________________________
 INTEGUMENTARY SYSTEM                                                                                                               
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
 MUSCULOSKELETAL SYSTEM                                                                                                             
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
 NERVOUS SYSTEM                                                                                                                     
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
 RESPIRATORY SYSTEM                                                                                                                 
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
 SPECIAL SENSES SYSTEM                                                                                                              
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
 URINARY SYSTEM                                                                                                                     
   Kidney                                             (10)         (10)         (10)         (10)         (10)         (10)         
      Mineralization, Diffuse                         10 (100%)    10 (100%)     9 (90%)     10 (100%)    10 (100%)     9 (90%)     
      Cortex, Pigmentation, Diffuse, Hemosiderin                                                                       10 (100%)    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    3                                                              
NTP Experiment-Test: 91001-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: SUBCHRON 90-DAY                                  O-CHLOROANILINE                                      Date: 10/20/04    
Route: GAVAGE                                                                                                     Time: 13:20:52    
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS MALE                     0 MG/KG      10 MG/KG     20 MG/KG     40 MG/KG     80 MG/KG     160             
                                                                                                                    MG/KG           
____________________________________________________________________________________________________________________________________
DISPOSITION SUMMARY                                                                                                                 
  Animals Initially In Study                          10           10           10           10           10           10           
  Early Deaths                                                                                                                      
    Natural Death                                                                             1                                     
  Survivors                                                                                                                         
    Terminal Sacrifice                                10           10           10            9           10           10           
  Animals Examined Microscopically                    10           10           10           10           10           10           
____________________________________________________________________________________________________________________________________
 ALIMENTARY SYSTEM                                                                                                                  
   Liver                                              (10)                      (1)          (1)                       (10)         
      Hepatodiaphragmatic Nodule                       1 (10%)                                                                      
      Pigmentation, Hemosiderin                                                                                        10 (100%)    
____________________________________________________________________________________________________________________________________
 CARDIOVASCULAR SYSTEM                                                                                                              
   Heart                                              (10)                                   (1)                       (10)         
      Myocardium, Degeneration, Chronic, Focal         2 (20%)                                                          2 (20%)     
____________________________________________________________________________________________________________________________________
 ENDOCRINE SYSTEM                                                                                                                   
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
 GENERAL BODY SYSTEM                                                                                                                
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
 GENITAL SYSTEM                                                                                                                     
   Preputial Gland                                    (10)                                   (1)                       (10)         
      Inflammation, Chronic Active                     6 (60%)                                                          6 (60%)     
____________________________________________________________________________________________________________________________________
 HEMATOPOIETIC SYSTEM                                                                                                               
   Bone Marrow                                        (10)         (10)         (10)         (10)         (10)         (10)         
      Erythroid Cell, Hyperplasia                                                             1 (10%)     10 (100%)    10 (100%)    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    4                                                              
NTP Experiment-Test: 91001-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: SUBCHRON 90-DAY                                  O-CHLOROANILINE                                      Date: 10/20/04    
Route: GAVAGE                                                                                                     Time: 13:20:52    
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS MALE                     0 MG/KG      10 MG/KG     20 MG/KG     40 MG/KG     80 MG/KG     160             
                                                                                                                    MG/KG           
____________________________________________________________________________________________________________________________________
HEMATOPOIETIC SYSTEM - CONT                                                                                                         
   Spleen                                             (10)         (10)         (10)         (10)         (10)         (10)         
      Hematopoietic Cell Proliferation                                                                    10 (100%)    10 (100%)    
      Pigmentation, Hemosiderin                                                                                         9 (90%)     
      Capsule, Fibrosis                                                                                   10 (100%)     9 (90%)     
____________________________________________________________________________________________________________________________________
 INTEGUMENTARY SYSTEM                                                                                                               
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
 MUSCULOSKELETAL SYSTEM                                                                                                             
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
 NERVOUS SYSTEM                                                                                                                     
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
 RESPIRATORY SYSTEM                                                                                                                 
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
 SPECIAL SENSES SYSTEM                                                                                                              
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
 URINARY SYSTEM                                                                                                                     
   Kidney                                             (10)         (10)         (10)         (10)         (10)         (10)         
      Mineralization, Diffuse                          9 (90%)     10 (100%)    10 (100%)    10 (100%)    10 (100%)     9 (90%)     
      Mineralization, Focal                            1 (10%)                                                                      
      Cortex, Pigmentation, Diffuse, Hemosiderin                                                                       10 (100%)    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    5                                                              
                             ------------------------------------------------------------                                           
                             ----------              END OF REPORT             ----------                                           
                             ------------------------------------------------------------